Editor's Choice – Focused Update on Paclitaxel Coated Technologies, from the 2024 European Society for Vascular Surgery (ESVS) Guidelines on the Management of Asymptomatic Peripheral Arterial Disease and Intermittent Claudication
Journal of Vascular Surgery · 2026-08 · 84 (2) · 548
DOI: 10.1016/j.jvs.2026.04.037 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Vascular Surgery, 2026-08. Verfasst von J. Nordanstig und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nordanstig, J., Hinchliffe, R., Lejay, A., & Behrendt, C. (2026). Editor's Choice – Focused Update on Paclitaxel Coated Technologies, from the 2024 European Society for Vascular Surgery (ESVS) Guidelines on the Management of Asymptomatic Peripheral Arterial Disease and Intermittent Claudication. Journal of Vascular Surgery, 84(2), 548. https://doi.org/10.1016/j.jvs.2026.04.037
Vancouver
Nordanstig J, Hinchliffe R, Lejay A, Behrendt C. Editor's Choice – Focused Update on Paclitaxel Coated Technologies, from the 2024 European Society for Vascular Surgery (ESVS) Guidelines on the Management of Asymptomatic Peripheral Arterial Disease and Intermittent Claudication. Journal of Vascular Surgery. 2026;84(2):548. doi:10.1016/j.jvs.2026.04.037
BibTeX
@article{Nordanstig2026,
author = {Nordanstig, J. and Hinchliffe, R. and Lejay, A. and Behrendt, C.-A.},
title = {Editor's Choice – Focused Update on Paclitaxel Coated Technologies, from the 2024 European Society for Vascular Surgery (ESVS) Guidelines on the Management of Asymptomatic Peripheral Arterial Disease and Intermittent Claudication},
journal = {Journal of Vascular Surgery},
year = {2026},
volume = {84},
number = {2},
pages = {548},
doi = {10.1016/j.jvs.2026.04.037}
}
EUVIMED